A novel, effective, and efficient strategy for treating sickle cell vaso-occlusive events in the infusion center setting

Blood Adv. 2023 Feb 14;7(3):410-413. doi: 10.1182/bloodadvances.2022007307.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Anemia, Sickle Cell* / complications
  • Anemia, Sickle Cell* / therapy
  • Erythrocytes, Abnormal
  • Humans
  • Pain*